Swiss: Lilly, Pfizer, Bayer fixed ED prices

Swiss authorities are accusing three drugmakers--Eli Lilly, Pfizer and Bayer--of forming an ED cartel. No, not the kind of cartel that's at war in Mexico, but the kind that colludes on prices. Authorities say the pharma firms are cloaking their price-fixing under a "recommended price" label; the companies have 20 days to respond. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.